User:Luke Edward Severinac/Sandbox 1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 10: Line 10:
==Active State==
==Active State==
-
In order to function as an endoprotease, Caspase-6 binds a <scene name='75/752344/Protein_ligand_real/1'>ligand</scene>, which can include neuronal proteins and tubulins [https://en.wikipedia.org/wiki/Tubulin], in its active site.[[Image:Binding grove active caspase 6.png|100 px|right|thumb|Substrate binding groove in Caspase-6. Blue - catalytic residues
+
In order to function as an endoprotease, Caspase-6 binds a <scene name='75/752344/Protein_ligand_real/1'>ligand</scene>, which can include neuronal proteins and [https://en.wikipedia.org/wiki/Tubulin tubulins], in its active site.[[Image:Binding grove active caspase 6.png|100 px|right|thumb|Substrate binding groove in Caspase-6. Blue - catalytic residues
yellow - ligand
yellow - ligand
red - generic surface]] This binding groove contains three critical amino acid residues necessary to perform cleavage of the peptide bonds. Together, <scene name='75/752344/His121_real/1'>His-121</scene>, <scene name='75/752344/Glu123_real/1'>Glu-123</scene>, and <scene name='75/752344/Cys163_real/1'>Cys-163</scene> form a <scene name='75/752344/Catalytic_triad_real/1'>catalytic triad</scene>[[Image:Cystine Aspartase.png|100 px|right|thumb|active site mechanism]]. In the theorized mechanism, His-121 acts as an acid catalyst, Glu-123 acts as a base catalyst to deprotonate Cys-163, which then acts as covalent catalyst.
red - generic surface]] This binding groove contains three critical amino acid residues necessary to perform cleavage of the peptide bonds. Together, <scene name='75/752344/His121_real/1'>His-121</scene>, <scene name='75/752344/Glu123_real/1'>Glu-123</scene>, and <scene name='75/752344/Cys163_real/1'>Cys-163</scene> form a <scene name='75/752344/Catalytic_triad_real/1'>catalytic triad</scene>[[Image:Cystine Aspartase.png|100 px|right|thumb|active site mechanism]]. In the theorized mechanism, His-121 acts as an acid catalyst, Glu-123 acts as a base catalyst to deprotonate Cys-163, which then acts as covalent catalyst.
==Zinc Inhibition==
==Zinc Inhibition==
-
Caspase-6 function is inhibited by the binding of a <scene name='75/752344/Zinc_caspase-6/1'>zinc</scene> ion[https://en.wikipedia.org/wiki/Zinc], which binds to an <scene name='75/752344/Caspase6_allosteric_site/1'>allosteric site</scene> instead of the <scene name='75/752344/Caspase6_allostericactiv_site/1'>active site</scene>. This allosteric site is located on the outside of the protein and is distal to the active site. The zinc ion is bound to <scene name='75/752344/Caspase6_allosteric_site_resid/1'>three amino acid residues</scene>, Lys-36, Glu-244, and His-287. Once the ion is bound to the protein, it is then stabilized by a <scene name='75/752344/H20_zinc_binding_casp/1'>water molecule</scene>. The binding of zinc at the exosite is suggested to cause a conformational change in the protein from an <scene name='75/752344/Catalytic_triad_real/1'>active state</scene> to an <scene name='75/752344/Inactive_catalytic_triad_casp/1'>inactive state</scene> that misaligns catalytic residues and inhibits activity of the enzyme. The residues in the active site no longer provide ideal interactions with the substrate and therefore, substrate does not bind. Zinc binding to the exosite is tightly regulated as it inhibits Caspase-6's critical role in initiation of apoptosis.
+
Caspase-6 function is inhibited by the binding of a <scene name='75/752344/Zinc_caspase-6/1'>zinc</scene> ion, which binds to an <scene name='75/752344/Caspase6_allosteric_site/1'>allosteric site</scene> instead of the <scene name='75/752344/Caspase6_allostericactiv_site/1'>active site</scene>. This allosteric site is located on the outside of the protein and is distal to the active site. The zinc ion is bound to <scene name='75/752344/Caspase6_allosteric_site_resid/1'>three amino acid residues</scene>, Lys-36, Glu-244, and His-287. Once the ion is bound to the protein, it is then stabilized by a <scene name='75/752344/H20_zinc_binding_casp/1'>water molecule</scene>. The binding of zinc at the exosite is suggested to cause a conformational change in the protein from an <scene name='75/752344/Catalytic_triad_real/1'>active state</scene> to an <scene name='75/752344/Inactive_catalytic_triad_casp/1'>inactive state</scene> that misaligns catalytic residues and inhibits activity of the enzyme. The residues in the active site no longer provide ideal interactions with the substrate and therefore, substrate does not bind. Zinc binding to the exosite is tightly regulated as it inhibits Caspase-6's critical role in initiation of apoptosis.
Primary inhibition of Caspase-6 occurs when a zinc ion binds to the <scene name='75/752344/Caspase6_allosteric_site_resid/1'>exosite</scene> containing Lys-36, Glu-244, and His-287 of the active dimer. In addition to these residues, the zinc interacts with <scene name='75/752344/H20_zinc_binding_casp/1'>one water molecule</scene> from the cytoplasm. It has been proposed that helices of the active dimer must rotate or move in some other way to provide these ideal interactions with zinc. This subtle shift is most likely the cause for allosteric inhibition. As the helices move to bind zinc, the amino acids of the active site become misaligned. The altered positions of the amino acids no longer provide ideal interactions for incoming substrates. After zinc binds, no new substrates enter the active site. Thus, Caspase-6 is effectively inhibited.
Primary inhibition of Caspase-6 occurs when a zinc ion binds to the <scene name='75/752344/Caspase6_allosteric_site_resid/1'>exosite</scene> containing Lys-36, Glu-244, and His-287 of the active dimer. In addition to these residues, the zinc interacts with <scene name='75/752344/H20_zinc_binding_casp/1'>one water molecule</scene> from the cytoplasm. It has been proposed that helices of the active dimer must rotate or move in some other way to provide these ideal interactions with zinc. This subtle shift is most likely the cause for allosteric inhibition. As the helices move to bind zinc, the amino acids of the active site become misaligned. The altered positions of the amino acids no longer provide ideal interactions for incoming substrates. After zinc binds, no new substrates enter the active site. Thus, Caspase-6 is effectively inhibited.
-
==Phosphorylation==
+
===Phosphorylation===
The function of Caspase-6 can be inhibited by phosphorylation of Ser-257. The exact mechanism of this reaction remains unidentified at the time of publication, but proceeds when ARK5 kinase is present. This modification can occur before and after zymogen activation or auto-processing. The phosphoryl group inhibits Caspase-6 through steric interference. When Ser-257 is phosphorylated, the amino acid residue interacts with <scene name='75/752344/Caspase-6_his-208/1'>Pro-201</scene>, causing a shift in the helices of Caspase-6. This is shown in the <scene name='75/752344/Caspase-6_s257d_mutant/1'>S257D Caspase-6 mutant</scene> mutant, whose mutation mimics phosphorylation. <ref name="Phosregcasp6subsbindgroove">PMID: 22483120 </ref> The shift misaligns and disrupts residues found in the active site. This conformational difference prevents the inter-subunit loop from entering during zymogen activation and the self-cleaved active dimer cannot be formed. Additionally, no new substrate is able to enter the active site.
The function of Caspase-6 can be inhibited by phosphorylation of Ser-257. The exact mechanism of this reaction remains unidentified at the time of publication, but proceeds when ARK5 kinase is present. This modification can occur before and after zymogen activation or auto-processing. The phosphoryl group inhibits Caspase-6 through steric interference. When Ser-257 is phosphorylated, the amino acid residue interacts with <scene name='75/752344/Caspase-6_his-208/1'>Pro-201</scene>, causing a shift in the helices of Caspase-6. This is shown in the <scene name='75/752344/Caspase-6_s257d_mutant/1'>S257D Caspase-6 mutant</scene> mutant, whose mutation mimics phosphorylation. <ref name="Phosregcasp6subsbindgroove">PMID: 22483120 </ref> The shift misaligns and disrupts residues found in the active site. This conformational difference prevents the inter-subunit loop from entering during zymogen activation and the self-cleaved active dimer cannot be formed. Additionally, no new substrate is able to enter the active site.
Line 24: Line 24:
=='''Medical Relevance'''==
=='''Medical Relevance'''==
===Caspase-6 involvement in Alzheimer's Disease===
===Caspase-6 involvement in Alzheimer's Disease===
-
Caspase-6 is known to be involved in many neurodegenerative diseases, one of which is Alzheimer's disease. Caspase-6 activity is associated with the formation of lesions within the Alzheimer's Disease (AD)[http://www.alz.org/].Lesions can be found in early stages of AD<ref name="ActiveRegofCasp6andNDdisease">PMID: 25340928 </ref>. A proapoptotic protein, p53, is present at increased levels within AD brains, which seems to directly increase the transcription of Caspase-6, which indirectly influences apoptosis of neurons. Future treatments of AD include selective inhibition of active Caspase-6 proteins; staining has found active Caspase-6 within the hippocampus and cortex of the brain within a varying severity of AD cases. This suggests that Caspase-6 plays a predominate role in the pathophysiology of AD. There has been research conducted that shows activation of Caspase-6 in AD could cause disruption of the cytoskeleton network of neurons and lead to neuronal apoptosis<ref name="ActiveRegofCasp6andNDdisease">PMID: 25340928 </ref>.
+
Caspase-6 is known to be involved in many neurodegenerative diseases, one of which is Alzheimer's disease (AD). Caspase-6 activity is associated with the formation of lesions within the [http://www.alz.org/ Alzheimer's Disease].Lesions can be found in early stages of AD<ref name="ActiveRegofCasp6andNDdisease">PMID: 25340928 </ref>. A proapoptotic protein, p53, is present at increased levels within AD brains, which seems to directly increase the transcription of Caspase-6, which indirectly influences apoptosis of neurons. Future treatments of AD include selective inhibition of active Caspase-6 proteins; staining has found active Caspase-6 within the hippocampus and cortex of the brain within a varying severity of AD cases. This suggests that Caspase-6 plays a predominate role in the pathophysiology of AD. There has been research conducted that shows activation of Caspase-6 in AD could cause disruption of the cytoskeleton network of neurons and lead to neuronal apoptosis<ref name="ActiveRegofCasp6andNDdisease">PMID: 25340928 </ref>.
==extra stuff==
==extra stuff==

Revision as of 13:29, 18 April 2017

Caspase-6 in Homo sapiens

Caspase-6

Drag the structure with the mouse to rotate

References

  1. Velazquez-Delgado EM, Hardy JA. Phosphorylation regulates assembly of the caspase-6 substrate-binding groove. Structure. 2012 Apr 4;20(4):742-51. Epub 2012 Apr 3. PMID:22483120 doi:10.1016/j.str.2012.02.003
  2. 2.0 2.1 Wang XJ, Cao Q, Zhang Y, Su XD. Activation and regulation of caspase-6 and its role in neurodegenerative diseases. Annu Rev Pharmacol Toxicol. 2015;55:553-72. doi:, 10.1146/annurev-pharmtox-010814-124414. Epub 2014 Oct 17. PMID:25340928 doi:http://dx.doi.org/10.1146/annurev-pharmtox-010814-124414
  3. Wang XJ, Cao Q, Liu X, Wang KT, Mi W, Zhang Y, Li LF, Leblanc AC, Su XD. Crystal structures of human caspase 6 reveal a new mechanism for intramolecular cleavage self-activation. EMBO Rep. 2010 Oct 1. PMID:20890311 doi:10.1038/embor.2010.141

Proteopedia Page Contributors and Editors (what is this?)

Luke Edward Severinac

Personal tools